Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of iMRI on Extent of Resection in Glioblastoma
NCT02379572Completed
- Sponsor
- University Hospital Tübingen
- Start
- Jun 2015
- Primary completion
- Jun 2020
- Countries
- 1
01
Overview
Open-label trial in glioblastoma (GBM) (2 arms), sponsored by University Hospital Tübingen. Primary endpoint: Complete resections in the postoperative MRI (T1+/-CM) within 48 hours after surgery. Started Jun 2015; status: completed.
02
Conditions
glioblastoma (GBM)
Beyond the preview
Go deeper on NCT02379572.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02379572.